Review



retrovirus production pbob ef1  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Addgene inc retrovirus production pbob ef1
    Retrovirus Production Pbob Ef1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 70 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrovirus production pbob ef1/product/Addgene inc
    Average 94 stars, based on 70 article reviews
    retrovirus production pbob ef1 - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    97
    ATCC retrovirus production phoenix eco cells
    Retrovirus Production Phoenix Eco Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrovirus production phoenix eco cells/product/ATCC
    Average 97 stars, based on 1 article reviews
    retrovirus production phoenix eco cells - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    95
    TaKaRa retrovirus production genomic dna
    Retrovirus Production Genomic Dna, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrovirus production genomic dna/product/TaKaRa
    Average 95 stars, based on 1 article reviews
    retrovirus production genomic dna - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    94
    Addgene inc retrovirus production pbob ef1
    Retrovirus Production Pbob Ef1, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrovirus production pbob ef1/product/Addgene inc
    Average 94 stars, based on 1 article reviews
    retrovirus production pbob ef1 - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    90
    AGC Techno Glass Co Ltd platinum-e cells, packaging cells for retrovirus production,
    Platinum E Cells, Packaging Cells For Retrovirus Production,, supplied by AGC Techno Glass Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/platinum-e cells, packaging cells for retrovirus production,/product/AGC Techno Glass Co Ltd
    Average 90 stars, based on 1 article reviews
    platinum-e cells, packaging cells for retrovirus production, - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    86
    TaKaRa retrovirus production
    Retrovirus Production, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrovirus production/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    retrovirus production - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    93
    Addgene inc pbabepuro flag ube2l3 retrovirus production
    Pbabepuro Flag Ube2l3 Retrovirus Production, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pbabepuro flag ube2l3 retrovirus production/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    pbabepuro flag ube2l3 retrovirus production - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    96
    Addgene inc retrovirus production

    Retrovirus Production, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/retrovirus production/product/Addgene inc
    Average 96 stars, based on 1 article reviews
    retrovirus production - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    86
    TaKaRa pmscv neo for retrovirus production clontech
    a Colony-forming units (CFUs) of various MLL fusions per 10,000 cells at third- and fourth-round passages under myeloid conditions ( n = 9: Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 7: MLL-ENL; n = 6: MLL-AF10). Hoxa9 expression normalized to that of Gapdh of first round colonies is shown as the relative value of the vector control (set to 1) ( n = 12, Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 8: MLL-ENL; n = 7: MLL-AF10). b Leukemogenic potential of MLL-AF4 and MLL-mAf4 in vivo. Murine HSPCs were transduced with MLL-AF4 constructs and transplanted into syngeneic mice (mock, n = 6; MLL-AF4, n = 10; MLL-mAf4, n = 30; MLL-mAf4 secondary transplantation n = 5). c mRNA expression of the MLL fusion genes in 293 T cells analyzed using a qPCR probe for the EPS region in the <t>pMSCV</t> neo plasmids ( n = 3). d Western blotting of MLL fusions in 293 T cells transfected with the MLL fusion expression vectors in c . Anti-beta tubulin (TUBB) (an internal standard) and neomycin phosphatase II (NPTII) antibodies (a gene transduction control) were included for comparison. e Virus particle production by the MLL fusion expression vectors was quantitated using qRT-PCR with the MSCV-EPS probe and absolute quantification methods ( n = 4). f Transduction of recombinant viruses carrying various MLL fusion genes in murine HSPCs were determined using qPCR probes for MSCV-EPS and the murine Gapdh locus ( n = 7: Vector, MLL-ENL, MLL-AF4, MLL-mAf4, Mock; n = 6: MLL-ΔFP; n = 4: MLL-AF10). g Cell numbers of murine HSPCs infected with various <t>retroviruses</t> carrying MLL fusion genes after 5 days of selection with G418 ( n = 3). h Relative mRNA expression of MLL fusion genes after antibiotic selection using qRT-PCR with the MSCV-EPS probe ( n = 3). i Western blotting of HSPCs transduced with retroviruses carrying MLL fusion genes cultured in G418 for 5 days, as shown in d . Data are presented as the mean ± SD of biologically independent replicates ( a , c , e , f , g , h ). P -value was calculated by one-way ANOVA followed by Tukey’s test ( a , c , e , f , g ). Western blotting was performed on two biological replicates ( d , i ). See also Supplementary Fig. . Source data are provided as a Source Data file.
    Pmscv Neo For Retrovirus Production Clontech, supplied by TaKaRa, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/pmscv neo for retrovirus production clontech/product/TaKaRa
    Average 86 stars, based on 1 article reviews
    pmscv neo for retrovirus production clontech - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    Image Search Results


    Journal: eLife

    Article Title: Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor

    doi: 10.7554/eLife.81286

    Figure Lengend Snippet:

    Article Snippet: Recombinant DNA reagent , p-gag/pol , Addgene , #14887 , Retrovirus production.

    Techniques: Transfection, Construct, Expressing, Purification, Modification, Plasmid Preparation, Mutagenesis, Recombinant, Sequencing, Bicinchoninic Acid Protein Assay, Protease Inhibitor, Software, Magnetic Beads, In Vitro, Binding Assay, Immunofluorescence

    a Colony-forming units (CFUs) of various MLL fusions per 10,000 cells at third- and fourth-round passages under myeloid conditions ( n = 9: Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 7: MLL-ENL; n = 6: MLL-AF10). Hoxa9 expression normalized to that of Gapdh of first round colonies is shown as the relative value of the vector control (set to 1) ( n = 12, Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 8: MLL-ENL; n = 7: MLL-AF10). b Leukemogenic potential of MLL-AF4 and MLL-mAf4 in vivo. Murine HSPCs were transduced with MLL-AF4 constructs and transplanted into syngeneic mice (mock, n = 6; MLL-AF4, n = 10; MLL-mAf4, n = 30; MLL-mAf4 secondary transplantation n = 5). c mRNA expression of the MLL fusion genes in 293 T cells analyzed using a qPCR probe for the EPS region in the pMSCV neo plasmids ( n = 3). d Western blotting of MLL fusions in 293 T cells transfected with the MLL fusion expression vectors in c . Anti-beta tubulin (TUBB) (an internal standard) and neomycin phosphatase II (NPTII) antibodies (a gene transduction control) were included for comparison. e Virus particle production by the MLL fusion expression vectors was quantitated using qRT-PCR with the MSCV-EPS probe and absolute quantification methods ( n = 4). f Transduction of recombinant viruses carrying various MLL fusion genes in murine HSPCs were determined using qPCR probes for MSCV-EPS and the murine Gapdh locus ( n = 7: Vector, MLL-ENL, MLL-AF4, MLL-mAf4, Mock; n = 6: MLL-ΔFP; n = 4: MLL-AF10). g Cell numbers of murine HSPCs infected with various retroviruses carrying MLL fusion genes after 5 days of selection with G418 ( n = 3). h Relative mRNA expression of MLL fusion genes after antibiotic selection using qRT-PCR with the MSCV-EPS probe ( n = 3). i Western blotting of HSPCs transduced with retroviruses carrying MLL fusion genes cultured in G418 for 5 days, as shown in d . Data are presented as the mean ± SD of biologically independent replicates ( a , c , e , f , g , h ). P -value was calculated by one-way ANOVA followed by Tukey’s test ( a , c , e , f , g ). Western blotting was performed on two biological replicates ( d , i ). See also Supplementary Fig. . Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4

    doi: 10.1038/s41467-022-34558-1

    Figure Lengend Snippet: a Colony-forming units (CFUs) of various MLL fusions per 10,000 cells at third- and fourth-round passages under myeloid conditions ( n = 9: Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 7: MLL-ENL; n = 6: MLL-AF10). Hoxa9 expression normalized to that of Gapdh of first round colonies is shown as the relative value of the vector control (set to 1) ( n = 12, Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 8: MLL-ENL; n = 7: MLL-AF10). b Leukemogenic potential of MLL-AF4 and MLL-mAf4 in vivo. Murine HSPCs were transduced with MLL-AF4 constructs and transplanted into syngeneic mice (mock, n = 6; MLL-AF4, n = 10; MLL-mAf4, n = 30; MLL-mAf4 secondary transplantation n = 5). c mRNA expression of the MLL fusion genes in 293 T cells analyzed using a qPCR probe for the EPS region in the pMSCV neo plasmids ( n = 3). d Western blotting of MLL fusions in 293 T cells transfected with the MLL fusion expression vectors in c . Anti-beta tubulin (TUBB) (an internal standard) and neomycin phosphatase II (NPTII) antibodies (a gene transduction control) were included for comparison. e Virus particle production by the MLL fusion expression vectors was quantitated using qRT-PCR with the MSCV-EPS probe and absolute quantification methods ( n = 4). f Transduction of recombinant viruses carrying various MLL fusion genes in murine HSPCs were determined using qPCR probes for MSCV-EPS and the murine Gapdh locus ( n = 7: Vector, MLL-ENL, MLL-AF4, MLL-mAf4, Mock; n = 6: MLL-ΔFP; n = 4: MLL-AF10). g Cell numbers of murine HSPCs infected with various retroviruses carrying MLL fusion genes after 5 days of selection with G418 ( n = 3). h Relative mRNA expression of MLL fusion genes after antibiotic selection using qRT-PCR with the MSCV-EPS probe ( n = 3). i Western blotting of HSPCs transduced with retroviruses carrying MLL fusion genes cultured in G418 for 5 days, as shown in d . Data are presented as the mean ± SD of biologically independent replicates ( a , c , e , f , g , h ). P -value was calculated by one-way ANOVA followed by Tukey’s test ( a , c , e , f , g ). Western blotting was performed on two biological replicates ( d , i ). See also Supplementary Fig. . Source data are provided as a Source Data file.

    Article Snippet: Various gene constructs were generated using restriction enzyme digestion or PCR-based mutagenesis and cloned into the pMSCV-neo (for retrovirus production) (Clontech), pCDH-MSCV-MCS-EF1-Hygro (for lentivirus production/transient expression), or the pCMV5 vectors (for transient expression).

    Techniques: Plasmid Preparation, Expressing, Control, In Vivo, Transduction, Construct, Transplantation Assay, Western Blot, Transfection, Comparison, Virus, Quantitative RT-PCR, Recombinant, Infection, Selection, Cell Culture

    a Domain swapping mutants of various MLL-AF4 mutants are shown in blue (mouse), white (human), and green (synonymous mutations). RNA and amino acid sequences of the post-transcriptional regulatory sequence (PTRS) of human AF4 (hPTRS) and its corresponding sequences of mouse AF4 (mPTRS) and the synonymous mutant (sPTRS). The minimum PTRS is indicated with a red rectangle. b Western blotting of MLL-AF4 mutants in 293 T cells, as described in Fig. . c Transforming ability of MLL-AF4 mutants under myeloid conditions, as described in Fig. ( n = 8: Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 5: MLL-AF4 sPTRS; n = 4: MLL-AF4 mPTRS, MLL-mAf4 hPTRS). Hoxa9 expression normalized to that of Gapdh of first round colonies is shown as the relative value of the MLL-mAf4 (set to 100) ( n = 9, Vector, MLL-AF4, MLL-mAf4; n = 8: MLL-ΔFP; n = 6: MLL-AF4 sPTRS; n = 5: MLL-AF4 mPTRS, MLL-mAf4 hPTRS). d Virus particle production by the MLL-AF4 mutant expression vectors. Virus particle production was quantitated as described in Fig. ( n = 4). e Relative transduction units of retroviruses carrying various MLL-AF4 mutant genes in murine HSPCs were determined as described in Fig. ( n = 7, Vector, MLL-AF4, MLL-mAf4; n = 6: MLL-ΔFP, Mock; n = 3: MLL-AF4 sPTRS). f Cell numbers of MLL-AF4 -transduced murine HSPCs after 5 days of G418 selection ( n = 3). g Transforming ability of MLL-AF4 mutants under an ex vivo lymphoid culture condition. Cell numbers per 10,000 cells at the third passage is shown ( n = 3). h Western blotting of the various MLL-AF4 synonymous mutants in 293 T cells, as described in Fig. . i Transforming ability of various MLL-AF4 synonymous mutants under myeloid conditions. CFUs per 10,000 cells in third- and fourth-round culture is shown ( n = 4). Hoxa9 expression normalized to Gapdh is shown as the relative value of MLL-mAF4 (set to 100) ( n = 4). Data are presented as the mean ± SD of indicated biologically independent replicates ( c , d , e , f , g , i P -value was calculated by one-way ANOVA followed by Tukey’s test ( c , d , e , f , i ). Western blotting was performed on two biological replicates ( b , h ). See also Supplementary Fig. . Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4

    doi: 10.1038/s41467-022-34558-1

    Figure Lengend Snippet: a Domain swapping mutants of various MLL-AF4 mutants are shown in blue (mouse), white (human), and green (synonymous mutations). RNA and amino acid sequences of the post-transcriptional regulatory sequence (PTRS) of human AF4 (hPTRS) and its corresponding sequences of mouse AF4 (mPTRS) and the synonymous mutant (sPTRS). The minimum PTRS is indicated with a red rectangle. b Western blotting of MLL-AF4 mutants in 293 T cells, as described in Fig. . c Transforming ability of MLL-AF4 mutants under myeloid conditions, as described in Fig. ( n = 8: Vector, MLL-ΔFP, MLL-AF4, MLL-mAf4; n = 5: MLL-AF4 sPTRS; n = 4: MLL-AF4 mPTRS, MLL-mAf4 hPTRS). Hoxa9 expression normalized to that of Gapdh of first round colonies is shown as the relative value of the MLL-mAf4 (set to 100) ( n = 9, Vector, MLL-AF4, MLL-mAf4; n = 8: MLL-ΔFP; n = 6: MLL-AF4 sPTRS; n = 5: MLL-AF4 mPTRS, MLL-mAf4 hPTRS). d Virus particle production by the MLL-AF4 mutant expression vectors. Virus particle production was quantitated as described in Fig. ( n = 4). e Relative transduction units of retroviruses carrying various MLL-AF4 mutant genes in murine HSPCs were determined as described in Fig. ( n = 7, Vector, MLL-AF4, MLL-mAf4; n = 6: MLL-ΔFP, Mock; n = 3: MLL-AF4 sPTRS). f Cell numbers of MLL-AF4 -transduced murine HSPCs after 5 days of G418 selection ( n = 3). g Transforming ability of MLL-AF4 mutants under an ex vivo lymphoid culture condition. Cell numbers per 10,000 cells at the third passage is shown ( n = 3). h Western blotting of the various MLL-AF4 synonymous mutants in 293 T cells, as described in Fig. . i Transforming ability of various MLL-AF4 synonymous mutants under myeloid conditions. CFUs per 10,000 cells in third- and fourth-round culture is shown ( n = 4). Hoxa9 expression normalized to Gapdh is shown as the relative value of MLL-mAF4 (set to 100) ( n = 4). Data are presented as the mean ± SD of indicated biologically independent replicates ( c , d , e , f , g , i P -value was calculated by one-way ANOVA followed by Tukey’s test ( c , d , e , f , i ). Western blotting was performed on two biological replicates ( b , h ). See also Supplementary Fig. . Source data are provided as a Source Data file.

    Article Snippet: Various gene constructs were generated using restriction enzyme digestion or PCR-based mutagenesis and cloned into the pMSCV-neo (for retrovirus production) (Clontech), pCDH-MSCV-MCS-EF1-Hygro (for lentivirus production/transient expression), or the pCMV5 vectors (for transient expression).

    Techniques: Sequencing, Mutagenesis, Western Blot, Plasmid Preparation, Expressing, Virus, Transduction, Selection, Ex Vivo

    a Leukemogenic potential of MLL-AF4 sPTRS in vivo. Murine HSPCs were transduced with retrovirus for the MLL-AF4 sPTRS construct and transplanted into syngeneic mice. MLL-AF4 sPTRS, n = 30. The B/M-MPAL and T-ALL cases were excluded as retrovirus genome integration was not detected (Supplementary Fig. ). The MLL-AF4 and MLL-mAf4 data (Fig. ) are shown for comparison. b The immunophenotype of MLL-AF4 sPTRS-mediated leukemia. Bone marrow cells from mice with MLL-AF4 sPTRS-mediated leukemia were analyzed via flow cytometry for the indicated markers. Unstained control is indicated in blue and stained sample indicated in red. c The expression of myeloid markers, Gr1 and Cd11b, in AML cells of MLL-AF4 sPTRS-leukemia. MLL-mAF4- and MLL-ENL-mediated AMLs were included for comparison. d qRT-PCR using bone marrow cells from mice with MLL-AF4 sPTRS-mediated leukemia. Expression levels normalized to Gapdh are shown relative to those of HSPCs. Data are presented as the mean ± SD of PCR triplicates. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: RNA-binding proteins of KHDRBS and IGF2BP families control the oncogenic activity of MLL-AF4

    doi: 10.1038/s41467-022-34558-1

    Figure Lengend Snippet: a Leukemogenic potential of MLL-AF4 sPTRS in vivo. Murine HSPCs were transduced with retrovirus for the MLL-AF4 sPTRS construct and transplanted into syngeneic mice. MLL-AF4 sPTRS, n = 30. The B/M-MPAL and T-ALL cases were excluded as retrovirus genome integration was not detected (Supplementary Fig. ). The MLL-AF4 and MLL-mAf4 data (Fig. ) are shown for comparison. b The immunophenotype of MLL-AF4 sPTRS-mediated leukemia. Bone marrow cells from mice with MLL-AF4 sPTRS-mediated leukemia were analyzed via flow cytometry for the indicated markers. Unstained control is indicated in blue and stained sample indicated in red. c The expression of myeloid markers, Gr1 and Cd11b, in AML cells of MLL-AF4 sPTRS-leukemia. MLL-mAF4- and MLL-ENL-mediated AMLs were included for comparison. d qRT-PCR using bone marrow cells from mice with MLL-AF4 sPTRS-mediated leukemia. Expression levels normalized to Gapdh are shown relative to those of HSPCs. Data are presented as the mean ± SD of PCR triplicates. See also Supplementary Fig. . Source data are provided as a Source Data file.

    Article Snippet: Various gene constructs were generated using restriction enzyme digestion or PCR-based mutagenesis and cloned into the pMSCV-neo (for retrovirus production) (Clontech), pCDH-MSCV-MCS-EF1-Hygro (for lentivirus production/transient expression), or the pCMV5 vectors (for transient expression).

    Techniques: In Vivo, Transduction, Construct, Comparison, Flow Cytometry, Control, Staining, Expressing, Quantitative RT-PCR